New Perspectives on Chronic Obstructive Pulmonary Disease by Celli BR, Singh D, Vogelmeier C, Agusti A

Get full text

Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment by Celli BR, Navaie M, Xu Z, Cho-Reyes S, Dembek C, Gilmer TP

Get full text

GOLD 2023 Update: Implications for Clinical Practice by Tamondong-Lachica DR, Skolnik N, Hurst JR, Marchetti N, Rabe APJ, Montes de Oca M, Celli BR

Get full text

Sputum Biomarkers in Wood and Tobacco Smoke Etiotypes of Chronic Obstructive Pulmonary Disease by Giraldo-Montoya ÁM, Torres-Duque CA, Giraldo-Cadavid LF, Laucho-Contreras ME, González-Flórez A, Santos AM, Tuta-Quintero EA, Celli BR, González-García M

Get full text

FEV1 is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease by Bikov A, Lange P, Anderson JA, Brook RD, Calverley PMA, Celli BR, Cowans NJ, Crim C, Dixon IJ, Martinez FJ, Newby DE, Yates JC, Vestbo J

Get full text

Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019 by Singh, D, Agusti, A, Anzueto, A, Barnes, PJ, Bourbeau, J, Celli, BR, Criner, GJ, Frith, P, Halpin, DMG, Han, M, López Varela, MV, Martinez, F, Montes De Oca, M, Papi, A, Pavord, ID, Roche, N, Sin, DD, Stockley, R, Vestbo, J, Wedzicha, JA, Vogelmeier, C

Current controversies in chronic obstructive pulmonary disease. A report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee by Criner, GJ, Martinez, FJ, Aaron, S, Agusti, A, Anzueto, A, Bafadhel, M, Barnes, PJ, Bourbeau, J, Chen, R, Ewig, J, Fabbri, LM, Frith, P, Halpin, DMG, Han, M, De Oca, M, Nishimura, M, O'Donnell, D, Papi, A, Pavord, I, Roche, N, Rodriguez-Roisin, R, Salvi, S, Singh, D, Sin, DD, Stockley, R, Varela, MV, Vestbo, J, Vogelmeier, CF, Washko, G, Wedzicha, JA, Celli, BR